Trials / Active Not Recruiting
Active Not RecruitingNCT04903132
Cellular Senescence and COVID-19 Long-Hauler Syndrome
Cellular Senescence and Its Contribution to COVID-19 Long-Hauler Syndrome
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated.
Conditions
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2021-05-26
- Last updated
- 2025-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04903132. Inclusion in this directory is not an endorsement.